Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity?
- PMID: 19723915
- PMCID: PMC3630792
- DOI: 10.1158/1055-9965.EPI-09-0080
Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity?
Abstract
Between 2001 and 2005, Blacks from the United States experienced a 32% higher pancreatic cancer death rate than Whites. Smoking, diabetes, and family history might explain some of this disparity, but prospective analyses are warranted. From 1984 to 2004, there were 6,243 pancreatic cancer deaths among Blacks (n = 48,525) and Whites (n = 1,011,864) in the Cancer Prevention Study II cohort. Multivariate Cox proportional hazards models yielded hazards ratios (HR) for known and suspected risk factors. Population attributable risks were computed and their effect on age-standardized mortality rates were evaluated. Blacks in this cohort had a 42% increased risk of pancreatic cancer mortality compared with Whites (HR, 1.42; 95% confidence intervals (CI), 1.28-1.58). Current smoking increased risk by >60% in both races; although Blacks smoked less intensely, risks were similar to Whites (HR(Black), 1.67; 95% CI, 1.28-2.18; HR(White), 1.82; 95% CI, 1.7-1.95). Obesity was significantly associated with pancreatic cancer mortality in Black men (HR, 1.66; 95% CI, 1.05-2.63), White men (HR, 1.42; 95% CI, 1.25-1.60), and White women (HR, 1.37; 95% CI, 1.22-1.54); results were null in Black women. The population attributable risk due to smoking, family history, diabetes, cholecystectomy, and overweight/obesity was 24.3% in Whites and 21.8% in Blacks. Smoking and overweight/obesity play a substantial a role in pancreatic cancer. Variation in the effect of these factors underscores the need to evaluate disease on the race-sex level. The inability to attribute excess disease in Blacks to currently known risk factors, even when combined with suspected risks, points to yet undetermined factors that play a role in the disease process.
Comment in
-
Vitamin D and racial disparities for pancreatic cancer - letter.Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):888; author reply 888. doi: 10.1158/1055-9965.EPI-09-0897. Epub 2010 Feb 16. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20160268 No abstract available.
References
-
- U.S. Cancer Statistics Working Group . United States Cancer Statistics: 1999–2004 Incidence and Mortality Web-based Report. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; Atlanta (GA): 2007. Available at: www.cdc.gov/uscs.
-
- Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2005. National Cancer Institute; Bethesda (MD): based on November 2007 SEER data submission, posted to the SEER web site, 2008. Available at: http://seer.cancer.gov/csr/1975_2005.
-
- Byers TE, Wolf HJ, Bauer KR, et al. The impact of socioeconomic status on survival after cancer in the United States : findings from the National Program of Cancer Registries Patterns of Care Study. Cancer. 2008;113:582–91. - PubMed
-
- Doubeni CA, Field TS, Buist DS, et al. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer. 2007;109:612–20. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
